MAPT and Alzheimer disease: Accumulation of tau and Aβ remains the key pathology specific to AD as set out by the latest biological definition of AD in research from a National Institute on Aging-Alzheimer’s Association working group [2], although recent advances in research have identified additional systems, cell types and molecular changes that are involved in AD pathogenesis.